In one cross-sectional study of 271 patients with clinical features of suspected MS onset, the combination of CSF NF-L and intrathecal immunoglobin G production had a sensitivity of 97% for detecting RRMS patients (55). This evidence concerns the gene NEFL and myeloid sarcoma.